Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis

Blood

Volumn 122, Issue 24, 2013, Pages 3964-3972

  Bulut, Gamze B ^a   Sulahian, Rita ^a   Yao, Huiyu ^a   Huang, Lily Jun Shen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; EPSIN; EPSIN 1; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CBL PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN BINDING; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVITY; ERYTHROID PRECURSOR CELL; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; CELL CULTURE; CELL LINE; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; KNOCKOUT MOUSE; METABOLISM; MUTATION; POLYCYTHEMIA; RNA INTERFERENCE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL LINE; CELLS, CULTURED; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; ENDOCYTOSIS; ERYTHROPOIETIN; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; MUTATION; POLYCYTHEMIA; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, ERYTHROPOIETIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84893499086     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-506212     Document Type: Article

References (48)

1. Constantinescu SN, Ghaffari S, Lodish HF. The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab. 1999;10(1): 18-23.
2. Richmond TD, Chohan M, Barber DL. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol. 2005;15(3):146-155.
3. Huang LJ, Shen YM, Bulut GB. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. Br J Haematol. 2010;148(6):844-852.
4. Levine RL. JAK-mutant myeloproliferative neoplasms. Curr Top Microbiol Immunol. 2012; 355:119-133.
5. Sulahian R, Cleaver O, Huang LJ. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood. 2009;113(21):5287-5297.
6. Walrafen P, Verdier F, Kadri Z, Chrétien S, Lacombe C, Mayeux P. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood. 2005;105(2):600-608.
7. Suzuki N, Ohneda O, Takahashi S, et al. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood. 2002;100(7):2279-2288.
8. Gross AW, Lodish HF. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem. 2006;281(4):2024-2032.
9. Skoda R, Prchal JT. Lessons from familial myeloproliferative disorders. Semin Hematol. 2005;42(4):266-273.
10. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005;24(19):3353-3359.
11. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503-533.
12. Thien CB, Langdon WY. Negative regulation of PTK signalling by Cbl proteins. Growth Factors. 2005;23(2):161-167.
13. Sigismund S, Polo S, Di Fiore PP. Signaling through monoubiquitination. Curr Top Microbiol Immunol. 2004;286:149-185.
14. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol. 2005;6(8):599-609.
15. Husnjak K, Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem. 2012;81:291-322.
16. Kales SC, Ryan PE, Nau MM, Lipkowitz S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 2010;70(12): 4789-4794.
17. Swaminathan G, Tsygankov AY. The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol. 2006;209(1):21-43.
18. Kales SC, Ryan PE, Lipkowitz S. Cbl exposes its RING finger. Nat Struct Mol Biol. 2012;19(2): 131-133.
19. Thien CB, Walker F, Langdon WY. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol Cell. 2001;7(2):355-365.
20. Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HC III. v-cbl, an oncogene from a dualrecombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sci USA. 1989;86(4):1168-1172.
21. Naramura M, Kole HK, Hu RJ, Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA. 1998;95(26):15547-15552.
22. Murphy MA, Schnall RG, Venter DJ, et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol. 1998;18(8):4872-4882.
23. Barber DL, Mason JM, Fukazawa T, et al. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins. Blood. 1997;89(9):3166-3174.
24. Odai H, Sasaki K, Iwamatsu A, et al. The protooncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem. 1995;270(18):10800-10805.
25. Horvath CA, Vanden Broeck D, Boulet GA, Bogers J, De Wolf MJ. Epsin: inducing membrane curvature. Int J Biochem Cell Biol. 2007;39(10): 1765-1770.
26. Sen A, Madhivanan K, Mukherjee D, Aguilar RC. The epsin protein family: coordinators of endocytosis and signaling. Biomol Concepts. 2012;3(2):117-126.
27. Wendland B. Epsins: adaptors in endocytosis? Nat Rev Mol Cell Biol. 2002;3(12):971-977.
28. Tong W, Sulahian R, Gross AW, Hendon N, Lodish HF, Huang LJ. The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and -independent mechanisms. J Biol Chem. 2006; 281(50):38930-38940.
29. Maine GN, Li H, Zaidi IW, Basrur V, Elenitoba-Johnson KS, Burstein E. A bimolecular affinity purification method under denaturing conditions for rapid isolation of a ubiquitinated protein for mass spectrometry analysis. Nat Protoc. 2010; 5(8):1447-1459.
30. Zhao L, Dong H, Zhang CC, et al. A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation. J Biol Chem. 2009;284(39):26988-26998.
31. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood. 1999;94(2):550-559.
32. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 1999;98(2): 181-191.
33. Kim TJ, Kim YT, Pillai S. Association of activated phosphatidylinositol 3-kinase with p120cbl in antigen receptor-ligated B cells. J Biol Chem. 1995;270(46):27504-27509.
34. Hartley D, Meisner H, Corvera S. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the protooncogene c-cbl. J Biol Chem. 1995;270(31): 18260-18263.
35. Songyang Z, Cantley LC. SH2 domain specificity determination using oriented phosphopeptide library. Methods Enzymol. 1995;254:523-535.
36. Hunter S, Burton EA, Wu SC, Anderson SM. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem. 1999;274(4):2097-2106.
37. Hakak Y, Hsu YS, Martin GS. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene. 2000;19(28):3164-3171.
38. Fournier TM, Lamorte L, Maroun CR, et al. Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion. Mol Biol Cell. 2000; 11(10):3397-3410.
39. Alcázar I, Cortés I, Zaballos A, et al. p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function. Blood. 2009;113(14): 3198-3208.
40. Kassenbrock CK, Anderson SM. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem. 2004; 279(27):28017-28027.
41. Reider A, Wendland B. Endocytic adaptors-social networking at the plasma membrane. J Cell Sci. 2011;124(Pt 10): 1613-1622.
42. Bulut GB, Sulahian R, Ma Y, Chi NW, Huang LJ. Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor. J Biol Chem. 2011;286(8): 6449-6457.
43. García Z, Silio V, Marqués M, et al. A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. EMBO J. 2006;25(20):4740-4751.
44. Ueki K, Fruman DA, Yballe CM, et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem. 2003;278(48): 48453-48466.
45. Jiménez C, Portela RA, Mellado M, et al. Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J Cell Biol. 2000; 151(2):249-262.
46. Chamberlain MD, Chan T, Oberg JC, et al. Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation. J Biol Chem. 2008;283(23): 15861-15868.
47. Fang D, Liu YC. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol. 2001;2(9): 870-875.
48. Meyer L, Deau B, Forejtníková H, et al. beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood. 2007;109(12):5215-5222.